ArticlePloS one2019

Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations.

Jason C Poole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.